Thursday 25th June 2020 Dr Ben Noble’s RCGP award-winning Cancer Maps is a popular interactive reference tool for GPs based on the NICE NG12 guideline; primarily, the tool is designed to be used during consultations to help clinicians assess possible cancer symptoms....
Friday 19th June 2020 For many patients, the relief of surviving their treatment or managing their condition can be followed with questions about other aspects of their life. Impotence can be very common after treatment for colorectal cancer; often affecting up to 90%...
Friday 27th March 2020 A digital rectal examination (DRE) is a useful screening tool, which can be used in conjunction with a PSA test, to help determine if a patient should be referred on a prostate cancer pathway. Prostate cancers may not necessarily secrete PSA;...
Friday 27th March 2020 Cancer charities and the Government have released updated guidance for people, including children, who are at very high risk of severe illness from coronavirus (COVID-19) because of an underlying health condition, and for their family, friends...
Friday 25th October 2019
Last week a report on Combating Cancer highlighted Kelly Smith, who visited the GP seven times in 6 months presenting vague symptoms. Eventually she was diagnosed with advanced bowel cancer through A&E.
Not fitting the typical demographic for bowel cancer and falling outside NICE guidelines, she was initially tested for other bowel conditions.
Our course on FIT explores similar patient stories and how to proceed when symptomatic patients with persistent symptoms present normal FIT results. A symptom diary like this one from Bowel Cancer UK could help safety net patients. Recording symptoms and tracking changes with this tool can also help to diagnose other bowel conditions.
Find out more:
Find out more: visit the GatewayC Faecal Immunochemical Test course here. 1 CPD credit is available upon completion of this course.
Thursday 25th June 2020 Dr Ben Noble’s RCGP award-winning Cancer Maps is a popular interactive reference tool for GPs based on the NICE NG12 guideline; primarily, the tool is designed to be used during consultations to help clinicians assess possible cancer symptoms....
Friday 19th June 2020 For many patients, the relief of surviving their treatment or managing their condition can be followed with questions about other aspects of their life. Impotence can be very common after treatment for colorectal cancer; often affecting up to 90%...
Friday 27th March 2020 A digital rectal examination (DRE) is a useful screening tool, which can be used in conjunction with a PSA test, to help determine if a patient should be referred on a prostate cancer pathway. Prostate cancers may not necessarily secrete PSA;...
Friday 27th March 2020 Cancer charities and the Government have released updated guidance for people, including children, who are at very high risk of severe illness from coronavirus (COVID-19) because of an underlying health condition, and for their family, friends...